Korn/Ferry International (NYSE:KFY) shares moved up 0.57% in last trading session and ended the day at $28.42. KFY Gross Margin is 96.20% and its has a return on assets of 7.00%. Korn/Ferry International (NYSE:KFY) quarterly performance is -20.98%.
On 25 February, Korn/Ferry International (NYSE:KFY) CEO Gary Burnison highlights the executive-level leadership traits that are the critical difference between keeping U.S. political candidates on the road to the White House – or packing up their campaigns.
Goldcorp Inc. (NYSE:GG) shares increased 3.32% in last trading session and ended the day at $14.32. GG Gross Margin is 6.90% and its has a return on assets of -15.90%. Goldcorp Inc. (NYSE:GG) quarterly performance is 22.47%.
Goldcorp Inc. (NYSE:GG) announced that it has reduced its annual dividend to $0.08 per share effective April 1, 2016 and amended its dividend payment schedule such that future dividends will be paid quarterly commencing in June 2016.
Annaly Capital Management, Inc. (NYSE:NLY) ended the last trading day at $10.13. Company weekly volatility is calculated as 1.52% and price to cash ratio as 5.43. Annaly Capital Management, Inc. (NYSE:NLY) showed a weekly performance of 1.40%.
On 24 February, Annaly Capital Management, Inc. (NYSE:NLY) announced its financial results for the quarter and year ended December 31, 2015. The Company reported GAAP net income for the quarter ended December 31, 2015 of $669.7 million, or $0.69 per average common share, compared to a GAAP net loss of ($627.5) million, or ($0.68) per average common share, for the quarter ended September 30, 2015, and a GAAP net loss of ($658.3) million, or ($0.71) per average common share, for the quarter ended December 31, 2014.
BroadSoft, Inc. (NASDAQ:BSFT) shares moved up 17.22% in last trading session and ended the day at $36.89. BSFT Gross Margin is 70.80% and its has a return on assets of -1.20%. BroadSoft, Inc. (NASDAQ:BSFT) quarterly performance is -7.96%.
BroadSoft, Inc. (NASDAQ:BSFT) reported fourth quarter non-GAAP EPS of $1.04 Monday morning, up from $0.65 in the previous year. The consensus estimate was for EPS of $0.67. The company expects to report first quarter non-GAAP EPS of $0.20 to $0.32 and between $1.90 and $2.10 for the full year. Analysts are expecting EPS of $0.24 and $1.93.
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) caters to the Healthcare space. Its weekly performance is 0.31%. On the last day of trading company shares ended up at $16.44. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) distance from 50-day simple moving average (SMA50) is -41.53%.
Atara Biotherapeutics Inc (NASDAQ:ATRA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday,Marketbeat.com reports. The firm presently has a $17.00 price objective on the biopharmaceutical company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 8.49% from the company’s current price.
Leave a Reply